2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Pain
27
Neoplasms
20
Cancer Pain
10
Colonic Neoplasms
7
Breakthrough Pain
7
Agnosia
7
Breast Neoplasms
5
Rectal Neoplasms
4
Prostatic Neoplasms
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Chronic Pain
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Pain, Postoperative
3
Lymphoma, Follicular
3
Breakthrough Cancer Pain
3
Waldenstrom Macroglobulinemia
2
Uterine Cervical Neoplasms
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Pleural Effusion, Malignant
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Myeloproliferative Disorders
2
Mycosis Fungoides
2
Interventions
Thoracoscopy
4
vandetanib
2
Povidone-Iodine
2
Cisplatin
2
dalotuzumab
1
X-Rays
1
Ultrasonography
1
Tyrosine Kinase Inhibitors
1
Tissue Plasminogen Activator
1
Thoracentesis
1
Tenecteplase
1
Surgical Procedures, Operative
1
Saline Solution
1
Receptors, Vascular Endothelial Growth Factor
1
Pleurodesis
1
Pemetrexed
1
Octreotide
1
Naproxen
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gemcitabine
1
Fentanyl
1
Diclofenac
1
Deoxyribonucleases
1
Dasatinib
1
Darbepoetin alfa
1
Clinical Laboratory Techniques
1
Chest Tubes
1
Cdc25C phosphatase (211-221)
1
Catheters, Indwelling
1
Biomarkers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pleural Effusion
×
Fentanyl
×
Clear all
NCT03973957
2019-06-04
TOPIC
The Cooper Health System
Phase NA
Unknown
124 enrolled